Amiodarone Hydrochloride: Brands, Price & Uses in Bangladesh

Amiodarone Hydrochloride is a Class III antiarrhythmic agent with a well-defined, evidence-graded set of uses:

FDA-Approved / Established Indications

• Life-threatening recurrent ventricular fibrillation (VF) and hemodynamically unstable ventricular tachycardia (VT) refractory to other antiarrhythmic therapy or in patients who could not tolerate other agents (oral therapy).
• Initiation of treatment and prophylaxis of frequently recurring VF and hemodynamically unstable VT in patients refractory to other therapy (intravenous formulation, hospital setting).

Guideline-Supported / Off-Label Uses (Commonly Used, Evidence-Based)

• Atrial fibrillation (AF) — for pharmacologic cardioversion and long-term rhythm (sinus rhythm) maintenance, particularly in patients with structural or ischemic heart disease where other antiarrhythmics are contraindicated. This is a guideline-supported but technically off-label use in many regulatory labels.
• Pulseless VT/VF cardiac arrest — used per Advanced Cardiac Life Support (ACLS) protocols as an adjunct to defibrillation and CPR.
• Supraventricular tachyarrhythmias (including in the setting of Wolff-Parkinson-White syndrome) when other measures fail — used adjunctively.

Because of its extensive toxicity profile, Amiodarone Hydrochloride is generally reserved for serious, life-threatening arrhythmias rather than used as a first-line agent, and should be initiated and monitored by physicians experienced in treating such arrhythmias.

General Principles

Dosing of Amiodarone Hydrochloride is individualized to the arrhythmia being treated and the patient's response, typically involving a loading phase followed by a lower maintenance dose because of its long half-life.

Renal impairment does not typically require dose adjustment, as Amiodarone Hydrochloride is minimally renally eliminated. Hepatic impairment requires caution and closer monitoring, as Amiodarone Hydrochloride itself can be hepatotoxic. See Precautions and Warnings for mandatory baseline and periodic monitoring requirements.

Boxed Warnings (Serious/Potentially Fatal)

• Pulmonary toxicity: can present as hypersensitivity pneumonitis or pulmonary fibrosis and can be fatal; requires baseline and periodic monitoring (see Precautions).
• Hepatotoxicity: can be severe and, rarely, fatal liver injury.
• Proarrhythmic effects: Amiodarone Hydrochloride can worsen existing arrhythmias or cause new ones, including torsades de pointes.

Common Side Effects

• Nausea, vomiting, decreased appetite, constipation
• Tremor, ataxia, peripheral neuropathy, fatigue, malaise
• Corneal microdeposits (occur in nearly all patients on long-term therapy; rarely affect vision)
• Photosensitivity (increased sunburn risk) and blue-gray skin discoloration with prolonged use

Other Serious Side Effects

• Thyroid dysfunction — both hypothyroidism and hyperthyroidism (due to the iodine content)
• Optic neuropathy/neuritis, which can rarely progress to vision loss
• Bradycardia and, with intravenous use, hypotension and infusion-site reactions